Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5647967 | 0.92 | TSHR (0.39) | TSHRALDH1A1 | |
| SCHEMBL29617180 | 0.75 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL29617181 | 0.75 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL9641014 | 0.73 | MEN1 (0.37) | TSHRALDH1A1LMNA | |
| SCHEMBL1447918 | 0.71 | — | — | |
| SCHEMBL3246343 | 0.70 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL646922 | 0.69 | — | — | |
| SCHEMBL29617173 | 0.69 | FAAH (0.41) | TSHRALDH1A1 | |
| SCHEMBL14892418 | 0.69 | SPHK1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL29617152 | 0.67 | FAAH (0.45) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102295642-B | 2-Aryimidazole is [1,2-a] pyridine-3-acetamide, Preparation Method And The Use also | Institute of Toxicology and Drugs, Chinese Academy of Military Medical Sciences (CN) | 2016-04-06 | — | — | CN | disclosed |
| CN-102295642-A | 2-aryl imidazo [1,2-a] pyridine-3-acetamide derivative and preparation method as well as application thereof | — | 2011-12-28 | — | — | CN | disclosed |
| US-7276600-B2 | Phthalocyanine derivatives and their applications in optical recording media | TSAI YEN CHENG | 2007-10-02 | — | — | US | disclosed |
| US-20060292494-A1 | Novel phthalocyanine derivatives, synthetic process thereof and their applications in optical recording media | TSAI YEN C | 2006-12-28 | — | — | US | disclosed |
| US-20060281026-A1 | Phthalocyanine derivatives and their applications in optical recording media | TSAI YEN C | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060292494-A1 | Novel phthalocyanine derivatives, synthetic process thereof and their applications in optical recording media | TRPC3, TRPA1, TRPC6 | TSHR 2593/4885ALDH1A1 883/4885LMNA 1137/4885 |
| US-20060281026-A1 | Phthalocyanine derivatives and their applications in optical recording media | CRY2, CACNA1C, CRY1 | TSHR 3982/4885ALDH1A1 1066/4885LMNA 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.